...
首页> 外文期刊>Journal of Neuro-Oncology >Intracranial relapse rates and patterns, and survival trends following post-resection cavity radiosurgery for patients with single intracranial metastases
【24h】

Intracranial relapse rates and patterns, and survival trends following post-resection cavity radiosurgery for patients with single intracranial metastases

机译:颅内单个转移灶患者切除术后腔内放疗后颅内复发率和模式以及生存趋势

获取原文
获取原文并翻译 | 示例
           

摘要

The objective of this study is to evaluate the patterns of relapse and survival trends in patients with single brain metastases treated with post-operative adjuvant Gamma knife stereotactic radiosurgery (GKS) without whole brain radiotherapy (WBRT). Retrospective analysis of all consecutive patients who underwent GKS to the tumor cavity following resection of solitary brain metastasis was performed at a single institution. Between March 2001 and June 2010, 56 patients underwent GKS to the resection cavity following resection of intracranial metastases; no patient received pre- or post-operative WBRT as an adjuvant (salvage WBRT was permissible). The mean marginal dose was 17.1 Gy (range 14–20 Gy). The mean follow-up period was 24 months (range 3–99 months). Five patients (8.9%) had local recurrence in the immediate vicinity of the resection cavity, qualifying as “local failures”, and 21 (37.5%) recurred at distant intracranial sites. Median intracranial recurrence free survival was 13 months. Median overall survival was 20.5 months. Salvage interventions were required in 26 patients, and included repeat radiosurgery in 17 patients, further surgery in two patients, and salvage WBRT in eight (14.3%; two of whom had also been locally salvaged with repeat radiosurgery) patients. As expected, avoidance of WBRT results in a high rate of intracranial failure (26/56 patients, 46%), even in well-selected patients with only single brain metastases. As anticipated, the majority of failures (21, 37.5%) are “distant intracranial”, and in this well-selected cohort the local failure rate is low (5/56 patients, 9%). All patients failing intracranially (46%) are potential candidates for salvage therapies, but WBRT as salvage was utilized in only 14.3% of patients. The median intracranial relapse-free was 13 months and overall survival was 20.5 months.
机译:这项研究的目的是评估在没有全脑放疗(WBRT)的情况下接受术后辅助伽马刀立体定向放射外科手术(GKS)的单脑转移患者的复发和生存趋势模式。在单个机构中对所有切除孤立性脑转移后接受GKS到肿瘤腔的连续患者进行回顾性分析。在2001年3月至2010年6月之间,有56例患者在颅内转移瘤切除后接受了GKS切除术。没有患者接受术前或术后WBRT的辅助治疗(允许使用挽救性WBRT)。平均边缘剂量为17.1 Gy(范围14-20 Gy)。平均随访期为24个月(范围3–99个月)。 5例(8.9%)在切除腔的附近局部复发,被称为“局部衰竭”,而21例(37.5%)在遥远的颅内部位复发。颅内无复发中位生存期为13个月。中位总生存期为20.5个月。 26例患者需要挽救干预措施,其中包括17例患者进行重复放射外科手术,2例患者进行进一步外科手术,以及8例(14.3%;其中2例还进行了局部放射外科手术局部挽救)患者进行WBRT挽救。正如预期的那样,避免WBRT会导致较高的颅内衰竭发生率(26/56例患者,占46%),即使在只有单脑转移的精心选择的患者中也是如此。正如预期的那样,大多数失败者(21%,37.5%)是“远距颅内”,在这一精心选择的队列中,局部失败率很低(5/56例患者,<9%)。所有颅内功能衰竭的患者(46%)都可能是挽救疗法的候选者,但只有14.3%的患者采用WBRT作为挽救疗法。颅内无复发中位时间为13个月,总生存期为20.5个月。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号